| Document |
Document Title |
|
WO/2023/118565A1 |
The invention provides a method for reducing the amount of DNA in a microbial fermentation product by adding a fungal DNase from Aspergillus oryzae to the resulting fermentation product during the recovery process.
|
|
WO/2023/117528A1 |
The present invention relates to a beverage composition comprising fermented acerola or fermented acerola extract. A further aspect of the invention is a method of preparing a beverage composition.
|
|
WO/2023/116738A1 |
Provided is a mutated lysophospholipase. Further provided are a gene encoding the lysophospholipase, a vector comprising the gene, and a host cell. In addition, further provided is a use of the lysophospholipase. The present invention al...
|
|
WO/2023/120896A1 |
The objective of the present invention relates to a novel Lactobacillus plantarum BNT_G401 strain and use thereof.
|
|
WO/2023/122770A1 |
Provided herein are compositions with enhanced protein content, protein compositions with improved functionality, and methods for the preparation thereof.
|
|
WO/2023/118140A1 |
The present invention relates to carbon fixation systems, wherein an inorganic carbon source is converted to acetyl-CoA. A system for the generation of acetyl-Coenzyme A (acetyl-CoA), comprising components necessary for the biochemical c...
|
|
WO/2023/118729A1 |
The present invention relates to a Limosilactobacillus fermentum strain chosen from the strain deposited with the CNCM on 17 November 2021 under number I-5777 or under number I-5778, for use thereof in the prevention and/or treatment of ...
|
|
WO/2023/117529A1 |
The present invention relates to a ready to drink beverage composition comprising fermented hemp or fermented hemp extract. A further aspect of the invention is a method of preparing a ready to drink beverage composition.
|
|
WO/2023/115896A1 |
The present disclosure relates to the field of biomedicine, and specifically relates to a bispecific NK cell agonist, a preparation method, and an application. The present disclosure provides a fused protein. The fused protein uses a CD1...
|
|
WO/2023/119207A1 |
This invention relates to use of a strain of probiotic bacteria or derivatives thereof for increasing feed efficiency, enhancing growth and/or productivity, improving body weight or body composition of a ruminant animal, and/or increasin...
|
|
WO/2023/115830A1 |
A complex microbial agent for promoting the growth of soybeans and improving the population abundance of probiotic microorganisms, prepared by mixing a Pseudomonas sp. H1 fermentation broth and a Bacillus altitudinis Y1 fermentation brot...
|
|
WO/2023/116223A1 |
Provided in the present invention are an Enterococcus faecalis and the use thereof. The Enterococcus faecalis has the deposit number of CCTCC NO: M 20211156, and the deposit date is 10 September 2021. The Enterococcus faecalis has good t...
|
|
WO/2023/116302A1 |
The present invention relates to a method for co-producing erythritol and arabinose from a xylose mother liquor. Xylose is separated by means of first chromatographic separation to obtain an extract solution and a raffinate, the extract ...
|
|
WO/2023/115809A1 |
Disclosed in the present invention are a high-content resuspendable microbial bulk drug, and a preparation thereof, a preparation method thereof, and the use of thereof. The method for preparing the microbial bulk drug comprises the foll...
|
|
WO/2023/119206A1 |
This invention relates to the use of a strain of lactic acid bacteria for improving the body weight or body composition of animals, such as ruminant and/or monogastric animals, improving feed efficiency, growth, productivity, and/or milk...
|
|
WO/2023/116262A1 |
Provided in the present invention is a formula of a culture medium for isolating the accompanying Calcarisporium arbuscula fungus of Lactarius lignyotus, which formula comprises the following raw materials, in parts by weight: 3-5 g of g...
|
|
WO/2023/116710A1 |
Provided are a spinosad high-yield strain and the use thereof. The strain has a deposit number of CCTCC NO: M20211261, and the strain can produce various types of spinosad with high yields.
|
|
WO/2023/116477A1 |
A method for detecting the bacterial filtration efficiency of a mask, which belongs to the technical field of mask detection. The method comprises the following steps: (1) pretreating a sample; (2) preparing a bacterial suspension for te...
|
|
WO/2023/117527A1 |
The present invention relates to a beverage composition comprising fermented verbena or fermented verbena extract. A further aspect of the invention is a method of preparing a beverage composition.
|
|
WO/2023/117526A1 |
The present invention relates to a beverage composition comprising fermented camomile or fermented camomile extract. A further aspect of the invention is a method of preparing a beverage composition.
|
|
WO/2023/116227A1 |
The present invention provides a microbial composition having a weight loss effect. The microbial composition comprises Lactobacillus gasseri and Akkermansia muciniphila; the ratio of viable count of the Lactobacillus gasseri and Akkerma...
|
|
WO/2023/116283A1 |
Provided is an Enterococcus lactis with the deposit number of CCTCC NO: M20211220, which is deposited in the China Center for Type Culture Collection. The provided Enterococcus lactis of CCTCC NO: M20211220 can still ensure a survival ra...
|
|
WO/2023/113431A1 |
The present invention relates to: a strain selected from the group consisting of Saccharomyces cerevisiae KCTC14779BP, Saccharomyces cerevisiae KCTC14780BP, Lactobacillus fructivorans KCTC14776BP, Bacillus paramycoides KCTC14777BP, and B...
|
|
WO/2023/109530A1 |
Provided is the use of oxidoreductase and a mutant thereof in the biosynthesis of nootkatone. The oxidoreductase is derived from Wickerhamomyces anomalus M15 and has a high ability to convert nootkatol, and an oxidoreductase mutant havin...
|
|
WO/2023/113541A1 |
The present invention relates to a pharmaceutical composition for preventing or treating cancer or inflammatory disease and a health functional food for preventing or ameliorating cancer or inflammatory disease, which contain extracellul...
|
|
WO/2023/109839A1 |
Provided are a fungus for continuously inducing accumulation of agarwood and the use thereof. The fungus Phaeoacremonium rubrigenum has a strain number of LX2018, and has a registration number of CGMCC No. 23266 in the China General Micr...
|
|
WO/2023/110750A1 |
Described are acyl-CoA hydrolase (ACH) variants variants showing an improved activity in converting 3-methylcrotonyl-CoA into 3-methylcrotonic acid or an increased activity in converting crotonyl-CoA into crotonic acid as well as methods...
|
|
WO/2023/108503A1 |
Provided are a construction method of engineering bacteria, engineering bacteria obtained by means of construction and use of same in the preparation of sclareol. The construction method comprises the following steps: a DNA fragment I wh...
|
|
WO/2023/111308A1 |
A method to reduce concentration of a VOC (volatile organic compound) in air in contact with a coated surface comprising: - providing a surface - encapsulation of whole microorganism of Pseudomonas putida in a sol-gel matrix - applicatio...
|
|
WO/2023/108505A1 |
Provided in the present application are a method for improving the SAM cofactor supply of Saccharomyces cerevisiae, an engineered yeast and the use thereof. The method comprises: introducing an MET6 gene, a cMTFHR gene, a LiMETK1 gene, a...
|
|
WO/2023/109728A1 |
A method for improving the biological fermentation level of acarbose. By means of controlling temperatures and dissolved oxygen levels of different gradients during a fermentation process, the accumulation of acarbose products is acceler...
|
|
WO/2023/109804A1 |
A preparation method for an algae active cell composite biofertilizer and a use thereof. The preparation method comprises: preparing a pinellia ternata lectin protein culture medium; preparing a controlled-release nanoparticle-encapsulat...
|
|
WO/2023/108055A1 |
The invention provides a Bacillus clausii strain comprising a purified microbial population that comprises one or more bacteria with a gyrB that shares at least 97% identity with SEQ ID NO: 1; and / or that comprises one or more bacteria...
|
|
WO/2023/106464A1 |
The present invention provides a novel diphenazine compound or an enantiomer or pharmaceutically acceptable salt thereof. A novel diphenazine compound or an enantiomer or pharmaceutically acceptable salt thereof according to the present ...
|
|
WO/2023/104005A1 |
Provided is an ester-producing yeast strain, wherein the yeast is a Pichia kudriavzevii C4.12 strain, of which the preservation number is CCTCC NO: M 2021124. Also provided are a microbial agent of the yeast and a preparation method ther...
|
|
WO/2023/106452A1 |
The present invention relates to a novel xanthone compound, an optical isomer thereof or a pharmaceutically acceptable salt thereof, the xanthone compound exhibiting cytotoxicity against a cancer cell line so as to inhibit cell growth, t...
|
|
WO/2023/104046A1 |
Provided are a recombinant strain containing an isoprenoid alcohol kinase gene and an isopentenyl phosphate kinase gene, and an application of the recombinant strain in the production of terpenoids. The recombinant strain comprises an is...
|
|
WO/2023/108080A1 |
The invention is directed to new Bacillus coagulans strain, which alone or in combination with other Bacilli strains can be used as probiotics or together with a prebiotic and a symbiotic. The invention also relates to a composition such...
|
|
WO/2023/102798A1 |
Provided are a chassis cell having an autotrophic capability, and a construction method therefor and a use thereof. The chassis cell having the autotrophic capability expresses a carbon sequestration pathway, comprising a carbon sequestr...
|
|
WO/2023/108077A1 |
The invention provides a Bacillus megaterium strain comprising a purified microbial population that comprises one or more bacteria with a gyrB that shares at least 97% identity with SEQ ID NO: 1; and / or that comprises one or more bacte...
|
|
WO/2023/103365A1 |
Provided are four engineering yeasts, which are respectively engineering yeast CE-P1 capable of synthesizing calenduloside E, with a deposit number of CGMCC No. 23731, engineering yeast IVA-P1 capable of synthesizing chikusetsusaponin IV...
|
|
WO/2023/102862A1 |
The present invention relates to the field of immobilized proteins, in particular to a method for preparing a polyhedra for wrapping foreign proteins. A bombyx mori cytoplasmic polyhedrin, and a fusion foreign protein having a bombyx mor...
|
|
WO/2023/107014A1 |
The present invention relates to a method of increasing the permeability of outer cellular structures to release intracellular proteins into a medium using a bacterial expression system comprising the steps of culturing a host cell, whic...
|
|
WO/2023/104957A1 |
The invention relates to a method for sequestering carbon or removing carbon dioxide from air using a bioreactor inoculated with autotrophic microorganisms, the carbon dioxide from air being the sole carbon source.
|
|
WO/2023/106444A1 |
The present invention relates to a novel Lactobacillus paracasei (NK112) strain for preventing or treating cognitive dysfunction and intestinal dysfunction. In addition, the present invention relates to a composition for prevention, trea...
|
|
WO/2023/104846A1 |
The present invention relates to mutated bacterial host cells with increased SpoVG polypeptide expression, and nucleic acid constructs and expression vectors encoding SpoVG polypeptides. The invention also relates to methods of producing...
|
|
WO/2023/102816A1 |
Provided are a fusion gene comprising a PhoD signal peptide and a rocF gene, an expression cassette comprising the fusion gene, and a recombinant expression vector. Also provided are a genetically engineered bacterium and a construction ...
|
|
WO/2023/098928A1 |
The present invention provides a strain of bacterium Bacillus weihenstephanensis CCM 9146 producing an antimicrobial protein substance effective against pathogenic bacteria having lecitinase activity.
|
|
WO/2023/101349A1 |
The present invention relates to a novel Enterococcus faecium LCM001 strain, and a use thereof. A culture medium of the novel Enterococcus faecium LCM001 strain (deposit number: KCTC 14669BP) according to the present invention can suppre...
|
|
WO/2023/097975A1 |
Provided are a recombinant Bacillus subtilis strain capable of producing D-allulose-3-epimerase and the use thereof, and a method for improving the expression amount of D-allulose-3-epimerase by means of screening a promoter and optimizi...
|
